U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 17:16:30 UTC 2023
Edited
by admin
on Sat Dec 16 17:16:30 UTC 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
9K8GNJ2874
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
NAXITAMAB
USAN   INN  
Official Name English
HUMANIZED 3F8
Common Name English
ANTI-GD2 MONOCLONAL ANTIBODY 3F8 HUMANIZED
Common Name English
NAXITAMAB [USAN]
Common Name English
HUMANIZED MONOCLONAL ANTIBODY HU3F8-IGG1
Common Name English
MONOCLONAL ANTIBODY HU3F8
Common Name English
naxitamab [INN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(GANGLIOSIDE GD2) (HUMANIZED MUS MUSCULUS CLONE HU3F8 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MUS MUSCULUS CLONE HU3F8 LIGHT-CHAIN, DIMER
Systematic Name English
HU3F8
Code English
ANTI-GD2 IGG3 MONOCLONAL ANTIBODY 3F8 HUMANIZED
Common Name English
Naxitamab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS BETA-1,4 N-ACETYLGALACTOSAMINYLTRANSFERASE 1 ((N-ACETYLNEURAMINYL)-GALACTOSYLGLUCOSYLCERAMIDE, GM2/GD2 SYNTHASE))HUMANIZED MOUSE MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-449) (MUS MUSCULUS VH (IGHV2-9*02 (79%
Systematic Name English
HUMANIZED ANTI-GD2 MONOCLONAL ANTIBODY 3F8
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 416313
Created by admin on Sat Dec 16 17:16:30 UTC 2023 , Edited by admin on Sat Dec 16 17:16:30 UTC 2023
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 17:16:30 UTC 2023 , Edited by admin on Sat Dec 16 17:16:30 UTC 2023
EU-Orphan Drug EU/3/18/2094
Created by admin on Sat Dec 16 17:16:30 UTC 2023 , Edited by admin on Sat Dec 16 17:16:30 UTC 2023
FDA ORPHAN DRUG 399613
Created by admin on Sat Dec 16 17:16:30 UTC 2023 , Edited by admin on Sat Dec 16 17:16:30 UTC 2023
Code System Code Type Description
CAS
1879925-92-4
Created by admin on Sat Dec 16 17:16:30 UTC 2023 , Edited by admin on Sat Dec 16 17:16:30 UTC 2023
PRIMARY
INN
10918
Created by admin on Sat Dec 16 17:16:30 UTC 2023 , Edited by admin on Sat Dec 16 17:16:30 UTC 2023
PRIMARY
DAILYMED
9K8GNJ2874
Created by admin on Sat Dec 16 17:16:30 UTC 2023 , Edited by admin on Sat Dec 16 17:16:30 UTC 2023
PRIMARY
EVMPD
SUB192785
Created by admin on Sat Dec 16 17:16:30 UTC 2023 , Edited by admin on Sat Dec 16 17:16:30 UTC 2023
PRIMARY
RXCUI
2474039
Created by admin on Sat Dec 16 17:16:30 UTC 2023 , Edited by admin on Sat Dec 16 17:16:30 UTC 2023
PRIMARY
NCI_THESAURUS
C123428
Created by admin on Sat Dec 16 17:16:30 UTC 2023 , Edited by admin on Sat Dec 16 17:16:30 UTC 2023
PRIMARY
FDA UNII
9K8GNJ2874
Created by admin on Sat Dec 16 17:16:30 UTC 2023 , Edited by admin on Sat Dec 16 17:16:30 UTC 2023
PRIMARY
From To
1_231 2_231
1_228 2_228
2_222 4_211
1_222 3_211
4_131 4_191
4_23 4_88
3_131 3_191
3_23 3_88
2_369 2_427
2_263 2_323
2_146 2_202
2_22 2_95
1_369 1_427
1_263 1_323
1_146 1_202
1_22 1_95
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_299
N 2_299
Related Record Type Details
SUB_CONCEPT->SUBSTANCE
LABELED -> NON-LABELED
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:ESTIMATED CHEMICAL